cgp 20712a has been researched along with adenine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hernández, J; Juan-Fita, MJ; Vargas, ML | 1 |
| Fernández-Belda, F; Fuente, T; Handschin, C; Hernandez-Cascales, J; Pérez-Schindler, J; Soler, F | 1 |
2 other study(ies) available for cgp 20712a and adenine
| Article | Year |
|---|---|
The phosphodiesterase 3 inhibitor cilostamide enhances inotropic responses to glucagon but not to dobutamine in rat ventricular myocardium.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adenine; Adrenergic beta-Antagonists; Animals; Cyclic AMP; Cyclic Nucleotide Phosphodiesterases, Type 3; Dobutamine; Dose-Response Relationship, Drug; Drug Synergism; Exonucleases; Female; Glucagon; Heart Ventricles; Imidazoles; In Vitro Techniques; Male; Myocardial Contraction; Phosphodiesterase I; Phosphodiesterase Inhibitors; Purinergic P1 Receptor Antagonists; Quinolones; Rats; Rats, Sprague-Dawley; Ventricular Function; Xanthines | 2005 |
PDE2 activity differs in right and left rat ventricular myocardium and differentially regulates β2 adrenoceptor-mediated effects.
Topics: Adenine; Adrenergic beta-2 Receptor Agonists; Adrenergic beta-Antagonists; Albuterol; Animals; Cyclic AMP; Cyclic Nucleotide Phosphodiesterases, Type 2; Heart Ventricles; Imidazoles; In Vitro Techniques; Myocardial Contraction; Myocardium; Phosphodiesterase Inhibitors; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, beta-2; RNA, Messenger | 2015 |